dresscry1
About
Growth metabolism volume by simply 18F-FDG-PET being a prognostic forecaster involving first-line pembrolizumab with regard to NSCLC individuals using PD-L1 ≥ 55.
Growth metabolism volume by simply 18F-FDG-PET being a prognostic forecaster involving first-line pembrolizumab with regard to NSCLC individuals using PD-L1 ≥ 55.